Using the pTau/Aβ1-42 ratio to group participants, 85.6% of those who had normal amyloid (A) markers but abnormal tau (T) or neuronal damage (N) markers were classified into the low-risk group for dementia. This evidence concerns the gene MAPT and dementia.